Vincent J. Milano
Net Worth

Last updated:

What is Vincent J. Milano net worth?

The estimated net worth of Mr. Vincent J. Milano is at least $4,006,962 as of 10 Aug 2023. He owns shares worth $3,819 as insider, has earned $178,333 from insider trading and has received compensation worth at least $3,824,810 in Idera Pharmaceuticals, Inc..

What is the salary of Vincent J. Milano?

Mr. Vincent J. Milano salary is $347,710 per year as Pres, Chief Executive Officer & Director in Idera Pharmaceuticals, Inc..

How old is Vincent J. Milano?

Mr. Vincent J. Milano is 61 years old, born in 1964.

What stocks does Vincent J. Milano currently own?

As insider, Mr. Vincent J. Milano owns shares in one company:

Company Title Shares Price per share Total value
Idera Pharmaceuticals, Inc. (IDRA) Pres, Chief Executive Officer & Director 8,987 $0.43 $3,819

What does Idera Pharmaceuticals, Inc. do?

Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating solid tumors, squamous cell carcinoma of the head and neck, and colorectal cancer. The company has a collaboration agreement with Bristol-Meyers Squibb. Idera Pharmaceuticals, Inc. was incorporated in 1989 and is headquartered in Exton, Pennsylvania.

Vincent J. Milano insider trading

Idera Pharmaceuticals, Inc.

Mr. Vincent J. Milano has made 5 insider trades between 2014-2023, according to the Form 4 filled with the SEC. Most recently he sold 3,283 units of IDRA stock worth $1,750 on 10 Aug 2023.

The largest trade he's ever made was exercising 200,000 units of IDRA stock on 12 Dec 2014. As of 10 Aug 2023 he still owns at least 8,987 units of IDRA stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 3,283 $0.53 $1,750
Sale
Common Stock 3,210 N/A N/A
Sale
Common Stock 2,740 $3.91 $10,700
Sale
Common Stock 37,169 $4.32 $160,533
Sale
Common Stock 3,006 $1.78 $5,351
Purchase
Common Stock 15,000 $2.93 $43,920
Purchase
Common Stock 10,000 $5.51 $55,100
Purchase
Common Stock 40,000 $1.97 $78,800
Purchase
Common Stock 200,000 $4 $799,200

Idera Pharmaceuticals key executives

Idera Pharmaceuticals, Inc. executives and other stock owners filed with the SEC: